Literature DB >> 24718672

The global burden of cardiovascular diseases: a challenge to improve.

Shanthi Mendis1, Oleg Chestnov.   

Abstract

There are many challenges that need to be overcome to address the global cardiovascular disease epidemic. They include (1) lack of multisectoral action to support reduction of behavioral risk factors and their determinants, (2) weak public health and health care system capacity for forging an accelerated national response, and (3) inefficient use of limited resources. To make progress, countries need to develop and implement multisectoral national action plans guided by the global action plan for prevention and control of noncommunicable diseases, strengthen surveillance and monitoring systems, and set national targets consistent with global voluntary targets, which are to be attained by 2025. In addition, a set of cost-effective preventive and curative interventions need to be prioritized. Further, resources need to be generated and capacity developed to ensure sustainable country-wide implementation of the prioritized interventions. According to WHO estimates, the implementation of a core set of very cost-effective interventions for prevention and control of cardiovascular disease requires about 4 % of current health spending in lower income countries, 2 % in lower middle income countries, and less than 1 % in upper middle income and high income countries.

Entities:  

Mesh:

Year:  2014        PMID: 24718672     DOI: 10.1007/s11886-014-0486-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  8 in total

1.  Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial.

Authors:  Shanthi Mendis; S Claiborne Johnston; Wu Fan; Olulola Oladapo; Ali Cameron; Mohammed F Faramawi
Journal:  Bull World Health Organ       Date:  2009-12-08       Impact factor: 9.408

2.  Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness.

Authors:  Michele Cecchini; Franco Sassi; Jeremy A Lauer; Yong Y Lee; Veronica Guajardo-Barron; Daniel Chisholm
Journal:  Lancet       Date:  2010-11-10       Impact factor: 79.321

Review 3.  Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol.

Authors:  Peter Anderson; Dan Chisholm; Daniela C Fuhr
Journal:  Lancet       Date:  2009-06-27       Impact factor: 79.321

4.  Salt reduction initiatives around the world.

Authors:  Jacqueline L Webster; Elizabeth K Dunford; Corinna Hawkes; Bruce C Neal
Journal:  J Hypertens       Date:  2011-06       Impact factor: 4.844

5.  Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.

Authors:  Roger Ndindjock; Jude Gedeon; Shanthi Mendis; Fred Paccaud; Pascal Bovet
Journal:  Bull World Health Organ       Date:  2011-02-17       Impact factor: 9.408

Review 6.  Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.

Authors:  Shanthi Mendis; Oleg Chestnov
Journal:  Prog Cardiovasc Dis       Date:  2013 Nov-Dec       Impact factor: 8.194

7.  Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.

Authors:  Mónica Ortegón; Stephen Lim; Dan Chisholm; Shanthi Mendis
Journal:  BMJ       Date:  2012-03-02

8.  Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions.

Authors:  S Mendis; Igbal Al Bashir; Lanka Dissanayake; Cherian Varghese; Ibtihal Fadhil; Esha Marhe; Boureima Sambo; Firdosi Mehta; Hind Elsayad; Idrisa Sow; Maltie Algoe; Herbert Tennakoon; Lai Die Truong; Le Thi Tuyet Lan; Dismond Huiuinato; Neelamni Hewageegana; Naiema A W Fahal; Goitom Mebrhatu; Gado Tshering; Oleg Chestnov
Journal:  Int J Hypertens       Date:  2012-11-29       Impact factor: 2.420

  8 in total
  8 in total

1.  Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.

Authors:  S Li; R X Xu; Y Zhang; Y L Guo; C G Zhu; G Liu; Q Dong; J J Li
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

2.  Hypertension in a Brazilian urban slum population.

Authors:  Alon Unger; Ridalva D M Felzemburgh; Robert E Snyder; Guilherme S Ribeiro; Sharif Mohr; Vinícius B A Costa; Astrid X T O Melendez; Renato B Reis; Francisco S Santana; Lee W Riley; Mitermayer G Reis; Albert I Ko
Journal:  J Urban Health       Date:  2015-06       Impact factor: 3.671

3.  Body mass index, cardiorespiratory fitness and cardiometabolic risk factors in youth from Portugal and Mozambique.

Authors:  F K dos Santos; A Prista; T N Q F Gomes; D Santos; A Damasceno; A Madeira; P T Katzmarzyk; J A R Maia
Journal:  Int J Obes (Lond)       Date:  2015-06-10       Impact factor: 5.095

Review 4.  A review on the potential of underutilized Blackjack (Biden Pilosa) naturally occurring in sub-Saharan Africa.

Authors:  Deodata V Mtenga; Asha S Ripanda
Journal:  Heliyon       Date:  2022-05-29

5.  Relationship between serum estrogen levels and blood stasis syndrome in postmenopausal women with coronary heart disease.

Authors:  Xin Liu; Chunyu Guo; Xiaojuan Ma; Rui Tian; Ying Zhang; Huijun Yin
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

6.  Spiromastixones Inhibit Foam Cell Formation via Regulation of Cholesterol Efflux and Uptake in RAW264.7 Macrophages.

Authors:  Chongming Wu; Ran Chen; Mingyue Liu; Dong Liu; Xin Li; Shuai Wang; Siwen Niu; Peng Guo; Wenhan Lin
Journal:  Mar Drugs       Date:  2015-10-14       Impact factor: 5.118

7.  Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients.

Authors:  Štefan Tóth; Ján Fedačko; Tímea Pekárová; Zdenka Hertelyová; Matan Katz; Adil Mughees; Jozef Kuzma; Peter Štefanič; Ivan Kopolovets; Daniel Pella
Journal:  Cardiol Ther       Date:  2017-06-16

8.  Strengthening complex systems for chronic disease prevention: a systematic review.

Authors:  Lori Baugh Littlejohns; Andrew Wilson
Journal:  BMC Public Health       Date:  2019-06-11       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.